Dr. Mobeen Rathore, M.D

NPI: 1245299320
Total Payments
$39,707
2024 Payments
$2,000
Companies
8
Transactions
34

Payment Breakdown by Category

Consulting$35,750 (90.0%)
Travel$2,333 (5.9%)
Food & Beverage$875.17 (2.2%)
Research$649.69 (1.6%)
Education$99.00 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $35,750 9 90.0%
Travel and Lodging $2,333 10 5.9%
Food and Beverage $875.17 13 2.2%
Unspecified $649.69 1 1.6%
Education $99.00 1 0.2%

Payments by Type

General
$39,057
33 transactions
Research
$649.69
1 transactions

Top Paying Companies

Company Total Records Latest Year
SANOFI PASTEUR INC. $14,126 21 $0 (2023)
GlaxoSmithKline, LLC. $9,660 2 $0 (2019)
ViiV Healthcare Company $6,670 2 $0 (2021)
Seqirus USA Inc $6,456 5 $0 (2021)
Gilead Sciences, Inc. $2,000 1 $0 (2024)
Eli Lilly and Company $649.69 1 $0 (2020)
Astellas Pharma US Inc $99.00 1 $0 (2018)
PORTOLA PHARMACEUTICALS, INC. $46.71 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,000 1 Gilead Sciences, Inc. ($2,000)
2023 $7,023 11 SANOFI PASTEUR INC. ($7,023)
2022 $7,103 10 SANOFI PASTEUR INC. ($7,103)
2021 $8,670 3 ViiV Healthcare Company ($6,670)
2020 $649.69 1 Eli Lilly and Company ($649.69)
2019 $7,867 2 GlaxoSmithKline, LLC. ($7,820)
2018 $6,395 6 Seqirus USA Inc ($4,456)

All Payment Transactions

34 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/05/2024 Gilead Sciences, Inc. Consulting Fee Cash or cash equivalent $2,000.00 General
01/26/2023 SANOFI PASTEUR INC. Consulting Fee Cash or cash equivalent $6,210.00 General
01/26/2023 SANOFI PASTEUR INC. Travel and Lodging Cash or cash equivalent $51.35 General
01/26/2023 SANOFI PASTEUR INC. Food and Beverage In-kind items and services $50.00 General
01/26/2023 SANOFI PASTEUR INC. Food and Beverage In-kind items and services $50.00 General
01/26/2023 SANOFI PASTEUR INC. Travel and Lodging Cash or cash equivalent $48.00 General
01/26/2023 SANOFI PASTEUR INC. Food and Beverage Cash or cash equivalent $41.38 General
01/26/2023 SANOFI PASTEUR INC. Food and Beverage In-kind items and services $35.00 General
01/26/2023 SANOFI PASTEUR INC. Food and Beverage Cash or cash equivalent $14.70 General
01/26/2023 SANOFI PASTEUR INC. Travel and Lodging Cash or cash equivalent $2.00 General
01/25/2023 SANOFI PASTEUR INC. Travel and Lodging In-kind items and services $403.92 General
01/25/2023 SANOFI PASTEUR INC. Travel and Lodging In-kind items and services $117.00 General
04/27/2022 SANOFI PASTEUR INC. Consulting Fee Cash or cash equivalent $6,210.00 General
04/27/2022 SANOFI PASTEUR INC. Travel and Lodging Cash or cash equivalent $81.43 General
04/27/2022 SANOFI PASTEUR INC. Food and Beverage In-kind items and services $54.00 General
04/27/2022 SANOFI PASTEUR INC. Food and Beverage In-kind items and services $50.00 General
04/27/2022 SANOFI PASTEUR INC. Food and Beverage Cash or cash equivalent $49.61 General
04/27/2022 SANOFI PASTEUR INC. Food and Beverage Cash or cash equivalent $25.69 General
04/27/2022 SANOFI PASTEUR INC. Food and Beverage Cash or cash equivalent $11.28 General
04/26/2022 SANOFI PASTEUR INC. Travel and Lodging In-kind items and services $362.51 General
04/26/2022 SANOFI PASTEUR INC. Travel and Lodging In-kind items and services $188.00 General
04/26/2022 SANOFI PASTEUR INC. Food and Beverage In-kind items and services $70.00 General
12/14/2021 ViiV Healthcare Company CABENUVA (Biological) Consulting Fee Cash or cash equivalent $3,220.00 General
Category: HIV
08/10/2021 Seqirus USA Inc Consulting Fee Cash or cash equivalent $2,000.00 General
04/27/2021 ViiV Healthcare Company DOVATO (Drug) Consulting Fee Cash or cash equivalent $3,450.00 General
Category: HIV

Research Studies & Clinical Trials

Study Name Company Amount Records
A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS Eli Lilly and Company $649.69 1

About Dr. Mobeen Rathore, M.D

Dr. Mobeen Rathore, M.D is a Pediatrics healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245299320.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mobeen Rathore, M.D has received a total of $39,707 in payments from pharmaceutical and medical device companies, with $2,000 received in 2024. These payments were reported across 34 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($35,750).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatric Infectious Diseases
  • Location Jacksonville, FL
  • Active Since 03/19/2006
  • Last Updated 07/01/2009
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1245299320

Products in Payments

  • DOVATO (Drug) $3,450
  • CABENUVA (Biological) $3,220
  • BEVYXXA (Biological) $46.71

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Jacksonville